Big data tells J&J that recent grads are more loyal than experienced hires

Eric Palmer The "people analytics team" at drugmaker Johnson & Johnson used big data analysis techniques on employees to figure out whether hiring people with experience ...

Novartis CEO eyes more cost cuts to satisfy margin demands

Tracy Staton Novartis execs are rolling up their sleeves for another round of cost cuts. "Very significant" cost cuts, CEO Joe Jimenez tells the Financial Times, partly from ...

Actavis has an eye on more deals, for ‘couple billion dollars’ or so

Damian Garde Actavis, still awaiting the close of its $ 66 billion buyout of Allergan, is on the lookout for more bolt-on acquisitions. FierceBiotech News

Need more on ex-Sanofi CEO Viehbacher’s sudden exit?

Carly Helfand If you haven't yet read enough about ex-Sanofi CEO Chris Viehbacher's departure, check out Bloomberg's latest. FiercePharma News

New numbers back the meme: Pharma does spend more on marketing than R&D

Tracy Staton FiercePharma News

Eyeing Eylea’s heirs, Regeneron spends more and more on R&D

Damian Garde Regeneron is pouring more money than ever into its well-respected R&D operation, spending big on a cadre of late-stage candidates the Big Biotech believes can outshine ...

Teva gets more than half of U.S. Copaxone patients converted to long-lasting version

Eric Palmer One of the key strategies being pursued by Teva Pharmaceutical Industries to protect itself against generic competition to Copaxone is to switch patients over to its new ...

Two more biotechs limp onto Wall Street with discounted debuts

Damian Garde Another hoped-for big week of biotech IPOs has come up well short, with two entrants downsizing their ambitions to make it out and a third reportedly thwarted by some bad ...

News flash for biopharma bosses: More than half your employees want to leave

Carly Helfand Biopharma employee looking for a new job? You're not alone. In fact, you're not even in the minority, a new report says. FiercePharma News

Pfizer amps up its ‘Get old’ campaign with more content, more social media

Tracy Staton What's #FOGO? Hint: Many of us have it. Another hint: Pfizer wants people to talk about it. FiercePharma News

Sanofi hits Lilly with more Lantus infringement charges

Carly Helfand Sanofi has already slapped Eli Lilly with one patent infringement lawsuit over its Lantus copy, effectively keeping the competitor off the market until ...

Study: Med students cozy with pharma reps more likely to dole out branded drugs

Emily Wasserman Doctors aren't the only ones to fall prey to free lunches and fuzzy promotional talks. Medical students who spend more time with& pharma reps are more likely ...
© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS